Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for gynecologic cancers

A N Rosenthal1

  • 1Gynaecology Cancer Research Unit, St. Bartholomew's Hospital, West Smithfield, London, UK.

Current Opinion in Oncology
|November 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis.

British journal of cancer·2014
Same author

Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer.

British journal of cancer·2013
Same author

Celebrities and screening: a measurable impact on high-grade cervical neoplasia diagnosis from the 'Jade Goody effect' in the UK.

British journal of cancer·2013
Same author

Breast cancer metastasising to the pelvis and abdomen: what the gynaecologist needs to know.

BJOG : an international journal of obstetrics and gynaecology·2012
Same author

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.

BJOG : an international journal of obstetrics and gynaecology·2012
Same author

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.

BJOG : an international journal of obstetrics and gynaecology·2011
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Early detection of gynecologic cancers through improved screening methods significantly reduces mortality. Novel technologies and refined programs show promise for better patient outcomes in gynecologic oncology.

Area of Science:

  • Gynecologic Oncology
  • Cancer Screening Technologies
  • Preventive Medicine

Background:

  • Despite advances, advanced gynecologic malignancy prognosis remains poor.
  • Early detection through screening is crucial for reducing mortality.
  • Established screening programs require refinement and innovation.

Purpose of the Study:

  • To highlight the potential benefits of novel screening technologies for gynecologic cancers.
  • To discuss refinements in established screening programs.
  • To explore cost-benefit and psychological aspects of screening.

Main Methods:

  • Investigation of novel serum and molecular markers.
  • Evaluation of automated Pap test slide-reading systems.
  • Analysis of cost-effectiveness and psychological impact of screening.

Related Experiment Videos

Main Results:

  • Emerging screening methods demonstrate significant potential.
  • Refinements to existing programs can enhance early detection rates.
  • Research is ongoing into the broader implications of screening.

Conclusions:

  • Improved screening strategies are vital for enhancing survival in gynecologic cancer.
  • Novel technologies and optimized programs offer promising avenues for early detection.
  • Further research is needed to fully assess the impact and implementation of new screening methods.